Associate Professor of Surgery, Massachusetts General Hospital
General Surgery
Dr. Sarah P. Thayer, MD
|
|
Give Review
Sarah Thayer practices General Surgery. She researched medicine at University of Virginia School of Medicine. She received awards:"America's Top Doctors", "America's Top Doctors for Cancer" and "Fellow (FACS)". Sarah Thayer is a published physician. She published 71 publications, including: 'Circulating Tumor Cells Found in Patients With Localized and Advanced Pancreatic Cancer.' Doctor Sarah P. Thayer, MD accepts Medicare payments and is registered with Medicare.gov.
Publications
- Circulating Tumor Cells Found in Patients With Localized and Advanced Pancreatic Cancer.
- High performing whipple patients: factors associated with short length of stay after open Pancreaticoduodenectomy.
- Not all mixed-type intraDuctal papillary mucinous neoplasms behave like main-Duct lesions: Implications of minimal involvement of the main pancreatic Duct.
- The influence of anesthesia on heart rate complexity during elective and urgent surgery in 128 patients.
- IPMN Involving the Main Pancreatic Duct: Biology, Epidemiology, and Long-Term Outcomes Following Resection.
- Accurate prediction of nodal status in preoperative patients with pancreatic Ductal adenocarcinoma using next-gen nanoparticle.
- Surgery for Small and Asymptomatic Branch-Duct IPMNs.
- Updated long-term outcomes and prognostic factors for patients with unresectable locally advanced pancreatic Cancer treated with intraoperative radiotherapy at the Mas...
- Branch duct intraductal papillary mucinous neoplasms: does cyst size change the tip of the scale? A critical Analysis of the revised international consensus guidelines...
- Understanding Hospital Readmissions After Pancreaticoduodenectomy: Can We Prevent Them? : A 10-Year Contemporary Experience with 1,173 Patients at the Massachusetts Ge...
- N0/N1, PNL, or LNR? The Effect of Lymph Node Number on Accurate Survival Prediction in Pancreatic Ductal Adenocarcinoma.
- Targeting the MAGE A3 antigen in pancreatic Cancer.
- 851 resected cystic Tumors of the pancreas: A 33-year experience at the Massachusetts General Hospital.
- Sonic Hedgehog in pancreatic Cancer: From bench to bedside, then back to the bench.
- Evolution of the Whipple procedure at the Massachusetts General Hospital.
- Pancreatic Ductal adenocarcinoma: Long-term survival does not equal cure.
- Intraductal papillary mucinous neoplasms: Does a family history of pancreatic Cancer matter?
- Pten is a major tumor suppressor in pancreatic Ductal adenocarcinoma and regulates an NF-?B-cytokine network.
- Implications of Incidentally Discovered, Nonfunctioning Pancreatic Endocrine Tumors: Short-term and Long-term Patient Outcomes.
- Prognosis of invasive intraDuctal papillary mucinous neoplasm depends on histological and precursor epithelial subtypes.
- Neutrophil granulocyte derived MMP-9 is a VEGF independent functional component of the angiogenic switch in pancreatic Ductal adenocarcinoma.
- Plectin-1 as a novel biomarker for pancreatic Cancer.
- Metastatic Tumors in the pancreas in the modern era.
- Novel xenograft and cell line derived from an invasive intraDuctal papillary mucinous neoplasm of the pancreas give new insights into molecular mechanisms.
- Added value of selected images embedded into radiology reports to referring clinicians.
- Invasive intraDuctal papillary mucinous carcinomas of the pancreas: predictors of survival and the role of lymph node ratio.
- Pancreatic Duct glands are distinct Ductal compartments that react to chronic injury and mediate Shh-induced metaplasia.
- Does the mechanism of lymph node invasion affect survival in patients with pancreatic Ductal adenocarcinoma?
- Mucin-producing neoplasms of the pancreas: an Analysis of distinguishing clinical and epidemiologic characteristics.
- Isolation and characterization of centroacinar/terminal Ductal progenitor cells in adult mouse pancreas.
- Plectin-1 is a biomarker of malignant pancreatic intraDuctal papillary mucinous neoplasms.
- Current trends in Pancreatic cystic neoplasms.
- Global genomic Analysis of intraductal papillary mucinous neoplasms of the pancreas reveals significant molecular differences compared to ductal adenocarcinoma.
- Management of mucin-producing cystic neoplasms of the pancreas.
- Magnetic resonance imaging monitors physiological changes with antihedgehog therapy in pancreatic adenoCarcinoma xenograft model.
- Pancreatic fistula rates after 462 distal pancreatectomies: staplers do not decrease fistula rates.
- Preoperative platelet count and survival prognosis in resected pancreatic Ductal adenocarcinoma.
- Implications and management of Pancreatic fistulas following Pancreaticoduodenectomy: the Massachusetts General Hospital experience.
- Quality of life in pancreatic cancer: Analysis by stage and treatment.
- Mucinous cystic neoplasm of the pancreas is not an aggressive entity: lessons from 163 resected patients.
- Debridement and closed packing for sterile or infected necrotizing pancreatitis: insights into indications and outcomes in 167 patients.
- Improved contemporary surgical management of insulinomas: a 25-year experience at the Massachusetts General Hospital.
- In vivo lineage tracing defines the role of acinar-to-Ductal transdifferentiation in inflammatory Ductal metaplasia.
- Middle pancreatectomy: indications, short- and long-term operative outcomes.
- Branch-Duct intraDuctal papillary mucinous neoplasms: observations in 145 patients who underwent resection.
- Distal pancreatectomy with splenic preservation revisited.
- Evolving patterns in the detection and outcomes of pancreatic Neuroendocrine neoplasms: the Massachusetts General Hospital experience from 1977 to 2005.
- Beta cell transdifferentiation does not contribute to preneoplastic/metaplastic Ductal lesions of the pancreas by genetic lineage tracing in vivo.
- A novel somatic mouse model to survey tumorigenic potential applied to the Hedgehog pathway.
- Epidermal growth factor receptor kinase domain mutations in esophageal and pancreatic adenoCarcinomas.
- Decreased inflammation and improved survival with recombinant human activated protein C treatment in experimental acute pancreatitis.
- Perioperative CA19-9 levels can predict stage and survival in patients with resectable pancreatic adenoCarcinoma.
- Implications and cost of Pancreatic leak following distal Pancreatic resection.
- Imaging of acute mesenteric ischemia using multidetector CT and CT angiography in a porcine model.
- Validation of a postresection pancreatic adenoCarcinoma nomogram for disease-specific survival.
- Pancreaticoduodenectomy.
- Main-Duct intraDuctal papillary mucinous neoplasms of the pancreas: clinical predictors of malignancy and long-term survival following resection.
- Incidental Pancreatic cysts: clinicopathologic characteristics and comparison with symptomatic patients.
- Complete dorsal pancreatectomy with preservation of the ventral pancreas: a new surgical technique.
- Incidental Pancreatic cysts: do we really know what we are watching?
- Hedgehog is an early and late mediator of pancreatic Cancer tumorigenesis.
- Identification of a novel kindred with familial pancreatitis and pancreatic Cancer.
- Degradation and inactivation of plasma tumor necrosis factor-alpha by Pancreatic proteases in experimental acute pancreatitis.
- Cytology Adds Value to Imaging Studies for Risk Assessment of Malignancy in Pancreatic Mucinous Cysts.
- International network of Cancer genome projects.
- The emerging role of the hedgehog signaling pathway in gastrointestinal Cancers.
- Parenteral lorazepam versus parenteral haloperidol for the control of psychotic disruptive behavior.
- Etanercept treatment patterns in managed-care patients with psoriasis or psoriatic arthritis.
- ANG II infusion promotes Abdominal aortic aneurysms independent of increased blood pressure in hypercholesterolemic mice.
- Enhanced primary tumor delineation in pancreatic adenoCarcinoma using ultrasmall super paramagnetic iron oxide nanoparticle-ferumoxytol: an initial experience with his...
Schools
Virginia Commonwealth University School Of Medicine
Massachusetts General Hospital
Memorial Sloan Kettering Rockerfeller Research Laboratory
Procedures Preformed
- Adrenalectomy
- Appendectomy, Laparoscopic
- Appendectomy, Open
- Biopsy of Breast
- View All
Conditions Treated
- Abdominal Pain
- Anal and Rectal Cancer
- Appendicitis
- Atelectasis
- View All
Doctors Specialties
- General Surgery
Accepted Insurances
Awards
- America's Top Doctors
- America's Top Doctors for Cancer
- Fellow (FACS)
Education
-
Massachusetts General Hospital -
University of Virginia School of Medicine
Hospital
-
Massachusetts General Hospital
Helpful Reviews
Similar Doctors
|
|
Dr. Marshall K. Bartlett, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Edward E. Whang, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Yulia Zak, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. William H. Kitchens, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Hideko H. Nakajima, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Marisa Cevasco, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Matthew W. Swisher, MD |
|
|
Dr. Anooradha Raman, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Christina R. Bess, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Claudius Conrad, MD |
|
|
Dr. Susan L. Troyan, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Monica E. Young, MD |
|
|
Dr. Michael R. Cassidy, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Chinwe S. Kpaduwa, MD
This Doctor is OpenDoctor Recommended.
|